{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:35:43Z","timestamp":1790778943855,"version":"4.1.0"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,29]]},"DOI":"10.18632\/oncotarget.4280","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T17:43:03Z","timestamp":1443548583000},"page":"27688-27699","source":"Crossref","is-referenced-by-count":45,"title":["FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer"],"prefix":"10.18632","volume":"6","author":[{"given":"Qipeng","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,6,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","journal-title":"Nature"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Nikitin, Afotey, Nikitin. Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers. Molecular & Cellular Oncology; 1\u20133. e963435.","DOI":"10.4161\/23723548.2014.963435"},{"key":"3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-407190-2.00016-2","article-title":"FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy","volume":"119","author":"Wierstra","year":"2013","journal-title":"Advances in cancer research"},{"key":"4","doi-asserted-by":"crossref","first-page":"e46317","DOI":"10.1371\/journal.pone.0046317","article-title":"ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival","volume":"7","author":"Gautvik","year":"2012","journal-title":"PloS one"},{"key":"5","doi-asserted-by":"crossref","first-page":"e52578","DOI":"10.1371\/journal.pone.0052578","article-title":"Targeting GRB\/ERK\/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells","volume":"7","author":"Ngan","year":"2012","journal-title":"PloS one"},{"key":"6","doi-asserted-by":"crossref","first-page":"e113478","DOI":"10.1371\/journal.pone.0113478","article-title":"Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance","volume":"9","author":"Cheung","year":"2014","journal-title":"PloS one"},{"key":"7","doi-asserted-by":"crossref","first-page":"e6593","DOI":"10.1371\/journal.pone.0006593","article-title":"FoxM1 is a general target for proteasome inhibitors","volume":"4","author":"Gartel","year":"2009","journal-title":"PloS one"},{"key":"8","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.febslet.2005.09.103","article-title":"Antibiotic susceptibility of mammalian mitochondrial translation","volume":"579","author":"Watanabe","year":"2005","journal-title":"FEBS letters"},{"key":"9","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1158\/1535-7163.MCT-08-0188","article-title":"Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression","volume":"7","author":"Lam","year":"2008","journal-title":"Molecular cancer therapeutics"},{"key":"10","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4161\/cc.8.12.8708","article-title":"A novel mode of FoxM1 regulation: positive auto-regulatory loop","volume":"8","author":"Gartel","year":"2009","journal-title":"Cell Cycle"},{"key":"11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nchem.1114","article-title":"The transcription factor FOXM1 is a cellular target of the natural product thiostrepton","volume":"3","author":"Balasubramanian","year":"2011","journal-title":"Nature chemistry"},{"key":"12","doi-asserted-by":"crossref","first-page":"e23790","DOI":"10.1371\/journal.pone.0023790","article-title":"Aberrant activation of ERK\/FOXM1 signaling cascade triggers the cell migration\/invasion in ovarian cancer cells","volume":"6","author":"Ngan","year":"2011","journal-title":"PloS one"},{"key":"13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1479-5876-12-134","article-title":"Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer","volume":"12","author":"Li","year":"2014","journal-title":"J Transl Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Schultz","year":"2013","journal-title":"Nat Commun"},{"key":"15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/0008-5472.CAN-10-2004","article-title":"Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis","volume":"71","author":"Kalin","year":"2011","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/onc.2012.5","article-title":"YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes","volume":"31","author":"Sekido","year":"2012","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ceb.2008.10.001","article-title":"The Hippo-YAP pathway: new connections between regulation of organ size and cancer","volume":"20","author":"Guan","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1478-811X-11-31","article-title":"The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells","volume":"11","author":"Xu","year":"2013","journal-title":"Cell Commun Signal"},{"key":"19","article-title":"Hippo-YAP signaling pathway: A new paradigm for cancer therapy","author":"Qin","year":"2014","journal-title":"Int J Cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.280.8.719","article-title":"Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers","volume":"280","author":"Casey","year":"1998","journal-title":"JAMA"},{"key":"21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jcp.1041630303","article-title":"Effect of lysophospholipids on signaling in the human Jurkat T cell line","volume":"163","author":"Mills","year":"1995","journal-title":"J Cell Physiol"},{"key":"22","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","article-title":"Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis","volume":"66","author":"Xu","year":"2006","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Moolenaar","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1388-1981(02)00179-8","article-title":"Lysophosphatidic acid is a bioactive mediator in ovarian cancer","volume":"1582","author":"Mills","year":"2002","journal-title":"Biochimica et biophysica acta"},{"key":"25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1556\/OH.2009.28631","article-title":"Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers","volume":"150","author":"Rigo","year":"2009","journal-title":"Orv Hetil"},{"key":"26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Chun","year":"2014","journal-title":"J Lipid Res"},{"key":"27","first-page":"1570","article-title":"A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells","volume":"17","author":"Xu","year":"2003","journal-title":"FASEB J"},{"key":"28","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells","volume":"66","author":"Xu","year":"2006","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1038\/sj.onc.1210093","article-title":"Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1535-7163.MCT-08-1106","article-title":"Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis\/metastasis of mouse ovarian cancer in immunocompetent mice","volume":"8","author":"Xu","year":"2009","journal-title":"Molecular cancer therapeutics"},{"key":"31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-12-407173-5.00004-2","article-title":"The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles","volume":"118","author":"Wierstra","year":"2013","journal-title":"Advances in cancer research"},{"key":"32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/mol.62.3.660","article-title":"Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific","volume":"62","author":"Xu","year":"2002","journal-title":"Molecular pharmacology"},{"key":"33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bbalip.2006.08.011","article-title":"Homo- and hetero-dimerization of LPA\/S1P receptors, OGR1 and GPR4","volume":"1761","author":"Xu","year":"2006","journal-title":"Biochimica et biophysica acta"},{"key":"34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jclinpath-2011-200212","article-title":"Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma","volume":"65","author":"Lassmann","year":"2012","journal-title":"J Clin Pathol"},{"key":"35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/mp9002255","article-title":"pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1","volume":"7","author":"Stayton","year":"2010","journal-title":"Mol Pharm"},{"key":"36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjc.6601610","article-title":"Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma","volume":"90","author":"Hauptmann","year":"2004","journal-title":"Br J Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4161\/cbt.13.1.18440","article-title":"Inhibition of the Rho\/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1alpha in human ovarian cancer cells","volume":"13","author":"Kurachi","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"38","doi-asserted-by":"crossref","first-page":"e103988","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance ofmorphological subtypes","volume":"9","author":"Helleman","year":"2014","journal-title":"PloS one"},{"key":"39","first-page":"870","article-title":"p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel","volume":"57","author":"Broggini","year":"1997","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-09-3875","article-title":"Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers","volume":"70","author":"Anderson","year":"2010","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-12-3859","article-title":"Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer","volume":"73","author":"Xie","year":"2013","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T15:50:50Z","timestamp":1589385050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,13]]},"references-count":41,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,9,29]]}},"alternative-id":["4280","26299613"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4280","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,13]]}}}